speb/financial-data huggingface dataset:
IMUX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -25579000.00
IMUX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -25579000.00
IMUX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -25579000.00
IMUX income_statement (quarterly, 2025-09-30) — Net Interest Income: 419000.00
IMUX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 419000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Net PPE: 1431000.00
IMUX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -67000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 10499000.00
IMUX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -25953000.00
IMUX income_statement (quarterly, 2025-09-30) — Normalized Income: -25579000.00
IMUX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -20140000.00
IMUX income_statement (quarterly, 2025-09-30) — Operating Income: -25993000.00
IMUX income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
IMUX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 9865059.00
IMUX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 818000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 2041000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 2582000.00
IMUX income_statement (quarterly, 2025-09-30) — Other Gand A: 5981000.00
IMUX income_statement (quarterly, 2025-09-30) — Other Income Expense: -5000.00
IMUX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 48000.00
IMUX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -5000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Other Payable: 569000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Other Properties: 1431000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Payables: 7918000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 25605000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 1767000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
IMUX balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 3146000.00
IMUX income_statement (quarterly, 2025-09-30) — Pretax Income: -25579000.00
IMUX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
IMUX cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -67000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Receivables: 177000.00
IMUX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 40000.00
IMUX income_statement (quarterly, 2025-09-30) — Research And Development: 20012000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -589271000.00
IMUX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 5981000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Share Issued: 9865059.00
IMUX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 3614000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 10499000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 10499000.00
IMUX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
IMUX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
IMUX balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 177000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Total Assets: 40704000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 10499000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Total Debt: 792000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 10499000.00
IMUX income_statement (quarterly, 2025-09-30) — Total Expenses: 25993000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 30205000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1431000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 126000.00
IMUX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -25993000.00
IMUX balance_sheet (quarterly, 2025-09-30) — Working Capital: 9194000.00
IMUX income_statement (annual, 2025-12-31) — +Operating Expense: 103228000.00
IMUX income_statement (quarterly, 2025-12-31) — +Operating Expense: 23327000.00
IMUX income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
IMUX income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
IMUX balance_sheet (annual, 2025-12-31) — Accounts Payable: 9493000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 9493000.00
IMUX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 599241000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 599241000.00
IMUX income_statement (annual, 2025-12-31) — Basic Average Shares: 15568803.00
IMUX income_statement (annual, 2025-12-31) — Basic EPS: -6.20
IMUX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 35668000.00
IMUX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 35132000.00
IMUX cash_flow (annual, 2025-12-31) — Capital Expenditure: -161000.00
IMUX cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -11000.00
IMUX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 577000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 577000.00
IMUX balance_sheet (annual, 2025-12-31) — Capital Stock: 9000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 9000.00
IMUX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 15483000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 15483000.00
IMUX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 15483000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 15483000.00
IMUX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 65577000.00
IMUX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 59000.00
IMUX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -161000.00
IMUX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -11000.00
IMUX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -85806000.00
IMUX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -19281000.00
IMUX cash_flow (annual, 2025-12-31) — Change In Account Payable: 1237000.00
IMUX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 2164000.00
IMUX cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 4477000.00
IMUX cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -398000.00
IMUX cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -3161000.00
IMUX cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -3116000.00
IMUX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -715000.00
IMUX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -322000.00
IMUX cash_flow (annual, 2025-12-31) — Change In Payable: 1237000.00
IMUX cash_flow (quarterly, 2025-12-31) — Change In Payable: 2164000.00
IMUX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 5714000.00
IMUX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 1766000.00
IMUX cash_flow (annual, 2025-12-31) — Change In Working Capital: 1838000.00
IMUX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -1672000.00
IMUX cash_flow (annual, 2025-12-31) — Changes In Cash: -20390000.00
IMUX cash_flow (quarterly, 2025-12-31) — Changes In Cash: -19233000.00
IMUX balance_sheet (annual, 2025-12-31) — Common Stock: 9000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Common Stock: 9000.00
IMUX balance_sheet (annual, 2025-12-31) — Common Stock Equity: -6673000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -6673000.00
IMUX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 65395000.00
IMUX cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
IMUX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 16477000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 16477000.00
IMUX balance_sheet (annual, 2025-12-31) — Current Assets: 22869000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Current Assets: 22869000.00
IMUX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 470000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 470000.00
IMUX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 470000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 470000.00
IMUX balance_sheet (annual, 2025-12-31) — Current Liabilities: 30618000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 30618000.00
IMUX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 168000.00
IMUX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 42000.00
IMUX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 168000.00
IMUX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 42000.00
IMUX income_statement (annual, 2025-12-31) — Diluted Average Shares: 15568803.00
IMUX income_statement (annual, 2025-12-31) — Diluted EPS: -6.20
IMUX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -97172000.00
IMUX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -19300000.00
IMUX income_statement (annual, 2025-12-31) — EBIT: -103228000.00
IMUX income_statement (quarterly, 2025-12-31) — EBIT: -23327000.00
IMUX income_statement (annual, 2025-12-31) — EBITDA: -103060000.00
IMUX income_statement (quarterly, 2025-12-31) — EBITDA: -23285000.00
IMUX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 205000.00
IMUX cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -416000.00
IMUX cash_flow (annual, 2025-12-31) — End Cash Position: 15483000.00
IMUX cash_flow (quarterly, 2025-12-31) — End Cash Position: 15483000.00
IMUX cash_flow (annual, 2025-12-31) — Financing Cash Flow: 65577000.00
IMUX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 59000.00
IMUX cash_flow (annual, 2025-12-31) — Free Cash Flow: -85967000.00
IMUX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -19292000.00
IMUX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 2648000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 2648000.00
IMUX income_statement (annual, 2025-12-31) — General And Administrative Expense: 21245000.00
IMUX income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 4258000.00
IMUX balance_sheet (annual, 2025-12-31) — Gross PPE: 1183000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1183000.00
IMUX income_statement (annual, 2025-12-31) — Interest Income: 1040000.00
IMUX income_statement (quarterly, 2025-12-31) — Interest Income: 197000.00
IMUX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1040000.00
IMUX income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 197000.00
IMUX balance_sheet (annual, 2025-12-31) — Invested Capital: -6673000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Invested Capital: -6673000.00
IMUX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -161000.00
IMUX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -11000.00
IMUX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 65395000.00
IMUX cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
IMUX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 107000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 107000.00
IMUX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 107000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 107000.00
IMUX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 65395000.00
IMUX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
IMUX cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
IMUX cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 0.00
IMUX income_statement (annual, 2025-12-31) — Net Income: -97172000.00
IMUX income_statement (quarterly, 2025-12-31) — Net Income: -19300000.00
IMUX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -97172000.00
IMUX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -19300000.00
IMUX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -97172000.00
IMUX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -19300000.00
IMUX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -97172000.00
IMUX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -19300000.00
IMUX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -97172000.00
IMUX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -19300000.00
IMUX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -97172000.00
IMUX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -19300000.00
IMUX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -97172000.00
IMUX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -19300000.00
IMUX income_statement (annual, 2025-12-31) — Net Interest Income: 1040000.00
IMUX income_statement (quarterly, 2025-12-31) — Net Interest Income: 197000.00
IMUX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 1040000.00
IMUX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 197000.00
IMUX balance_sheet (annual, 2025-12-31) — Net PPE: 1183000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Net PPE: 1183000.00
IMUX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -161000.00
IMUX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -11000.00
IMUX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -6673000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -6673000.00
IMUX income_statement (annual, 2025-12-31) — Normalized EBITDA: -103060000.00
IMUX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -23285000.00
IMUX income_statement (annual, 2025-12-31) — Normalized Income: -97172000.00
IMUX income_statement (quarterly, 2025-12-31) — Normalized Income: -19300000.00
IMUX cash_flow (annual, 2025-12-31) — Operating Cash Flow: -85806000.00
IMUX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -19281000.00
IMUX income_statement (annual, 2025-12-31) — Operating Income: -103228000.00
IMUX income_statement (quarterly, 2025-12-31) — Operating Income: -23327000.00
IMUX income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
IMUX income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
IMUX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 12038262.00
IMUX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 12038262.00
IMUX balance_sheet (annual, 2025-12-31) — Other Current Assets: 1200000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 1200000.00
IMUX balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 1365000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 1365000.00
IMUX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 2648000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 2648000.00
IMUX income_statement (annual, 2025-12-31) — Other Gand A: 21245000.00
IMUX income_statement (quarterly, 2025-12-31) — Other Gand A: 4258000.00
IMUX income_statement (annual, 2025-12-31) — Other Income Expense: 5016000.00
IMUX income_statement (quarterly, 2025-12-31) — Other Income Expense: 3830000.00
IMUX cash_flow (annual, 2025-12-31) — Other Non Cash Items: 497000.00
IMUX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 341000.00
IMUX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 5016000.00
IMUX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 3830000.00
IMUX balance_sheet (annual, 2025-12-31) — Other Payable: 645000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Other Payable: 645000.00
IMUX balance_sheet (annual, 2025-12-31) — Other Properties: 1183000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Other Properties: 1183000.00
IMUX balance_sheet (annual, 2025-12-31) — Other Receivables: 3789000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Other Receivables: 3789000.00
IMUX balance_sheet (annual, 2025-12-31) — Payables: 10138000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Payables: 10138000.00
IMUX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 26615000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 26615000.00
IMUX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2168000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2168000.00
IMUX balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
IMUX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
IMUX balance_sheet (annual, 2025-12-31) — Prepaid Assets: 2064000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 2064000.00
IMUX income_statement (annual, 2025-12-31) — Pretax Income: -97172000.00
IMUX income_statement (quarterly, 2025-12-31) — Pretax Income: -19300000.00
IMUX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 182000.00
IMUX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 59000.00
IMUX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -161000.00
IMUX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -11000.00
IMUX balance_sheet (annual, 2025-12-31) — Receivables: 4122000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Receivables: 4122000.00
IMUX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 168000.00
IMUX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 42000.00
IMUX income_statement (annual, 2025-12-31) — Research And Development: 81983000.00
IMUX income_statement (quarterly, 2025-12-31) — Research And Development: 19069000.00
IMUX balance_sheet (annual, 2025-12-31) — Retained Earnings: -608571000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -608571000.00
IMUX income_statement (annual, 2025-12-31) — Selling General And Administration: 21245000.00
IMUX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 4258000.00
IMUX balance_sheet (annual, 2025-12-31) — Share Issued: 12038262.00
IMUX balance_sheet (quarterly, 2025-12-31) — Share Issued: 12038262.00
IMUX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 8863000.00
IMUX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1308000.00
IMUX balance_sheet (annual, 2025-12-31) — Stockholders Equity: -6673000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -6673000.00
IMUX balance_sheet (annual, 2025-12-31) — Tangible Book Value: -6673000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -6673000.00
IMUX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IMUX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IMUX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
IMUX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
IMUX balance_sheet (annual, 2025-12-31) — Taxes Receivable: 333000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 333000.00
IMUX balance_sheet (annual, 2025-12-31) — Total Assets: 24052000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Total Assets: 24052000.00
IMUX balance_sheet (annual, 2025-12-31) — Total Capitalization: -6673000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -6673000.00
IMUX balance_sheet (annual, 2025-12-31) — Total Debt: 577000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Total Debt: 577000.00
IMUX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -6673000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -6673000.00
IMUX income_statement (annual, 2025-12-31) — Total Expenses: 103228000.00
IMUX income_statement (quarterly, 2025-12-31) — Total Expenses: 23327000.00
IMUX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 30725000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 30725000.00
IMUX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1183000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1183000.00
IMUX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 107000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 107000.00
IMUX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -103228000.00
IMUX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -23327000.00
IMUX balance_sheet (annual, 2025-12-31) — Working Capital: -7749000.00
IMUX balance_sheet (quarterly, 2025-12-31) — Working Capital: -7749000.00
IMUX income_statement (quarterly, 2026-03-31) — +Operating Expense: 33235000.00
IMUX income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
IMUX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 10513000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 789324000.00
IMUX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 30136324.00
IMUX income_statement (quarterly, 2026-03-31) — Basic EPS: -1.08
IMUX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 15483000.00
IMUX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -2000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 421000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 11000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 186629000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 186629000.00
IMUX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -2000.00
IMUX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -17301000.00
IMUX cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 1091000.00
IMUX cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 4208000.00
IMUX cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 5214000.00
IMUX cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 124000.00
IMUX cash_flow (quarterly, 2026-03-31) — Change In Payable: 1091000.00
IMUX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 5299000.00
IMUX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 10637000.00
IMUX cash_flow (quarterly, 2026-03-31) — Changes In Cash: 171339000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Common Stock: 11000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 151233000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 21552000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Current Assets: 188759000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 275000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 275000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 38363000.00
IMUX cash_flow (quarterly, 2026-03-31) — Depreciation: 33000.00
IMUX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 33000.00
IMUX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 33000.00
IMUX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 30136324.00
IMUX income_statement (quarterly, 2026-03-31) — Diluted EPS: -1.08
IMUX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -32588000.00
IMUX income_statement (quarterly, 2026-03-31) — EBIT: -33235000.00
IMUX income_statement (quarterly, 2026-03-31) — EBITDA: -33202000.00
IMUX cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -193000.00
IMUX cash_flow (quarterly, 2026-03-31) — End Cash Position: 186629000.00
IMUX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 188642000.00
IMUX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -17303000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 3057000.00
IMUX income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 7609000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 983000.00
IMUX income_statement (quarterly, 2026-03-31) — Interest Income: 760000.00
IMUX income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 760000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 151233000.00
IMUX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -2000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 146000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 146000.00
IMUX income_statement (quarterly, 2026-03-31) — Net Income: -32588000.00
IMUX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -32588000.00
IMUX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -32588000.00
IMUX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -32588000.00
IMUX income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -32588000.00
IMUX cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -32588000.00
IMUX income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -32588000.00
IMUX income_statement (quarterly, 2026-03-31) — Net Interest Income: 760000.00
IMUX income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 760000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Net PPE: 983000.00
IMUX cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -2000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 151233000.00
IMUX income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -33202000.00
IMUX income_statement (quarterly, 2026-03-31) — Normalized Income: -32588000.00
IMUX cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -17301000.00
IMUX income_statement (quarterly, 2026-03-31) — Operating Income: -33235000.00
IMUX income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
IMUX balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 13621483.00
IMUX balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1059000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 4645000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 3057000.00
IMUX income_statement (quarterly, 2026-03-31) — Other Gand A: 7609000.00
IMUX income_statement (quarterly, 2026-03-31) — Other Income Expense: -113000.00
IMUX cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 151000.00
IMUX income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -113000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Other Payable: 498000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Other Properties: 983000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Payables: 11011000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 32563000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 880000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
IMUX balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 717000.00
IMUX income_statement (quarterly, 2026-03-31) — Pretax Income: -32588000.00
IMUX cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -2000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Receivables: 354000.00
IMUX income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 33000.00
IMUX income_statement (quarterly, 2026-03-31) — Research And Development: 25626000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -641159000.00
IMUX income_statement (quarterly, 2026-03-31) — Selling General And Administration: 7609000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Share Issued: 13621483.00
IMUX cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 4466000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 151233000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 151233000.00
IMUX income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
IMUX income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
IMUX balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 354000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Total Assets: 189742000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 151233000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Total Debt: 421000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 151233000.00
IMUX income_statement (quarterly, 2026-03-31) — Total Expenses: 33235000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 38509000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 983000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 146000.00
IMUX income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -33235000.00
IMUX balance_sheet (quarterly, 2026-03-31) — Working Capital: 150396000.00
IMVT income_statement (annual, 2022-03-31) — Basic Average Shares: 109679256.00
IMVT income_statement (annual, 2022-03-31) — Basic EPS: -1.43
IMVT balance_sheet (annual, 2022-03-31) — Cash Financial: 493817000.00
IMVT income_statement (annual, 2022-03-31) — Diluted Average Shares: 109679256.00
IMVT income_statement (annual, 2022-03-31) — Diluted EPS: -1.43
IMVT balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 1219000.00
IMVT balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 1219000.00
IMVT cash_flow (annual, 2022-03-31) — Long Term Debt Payments: 0.00
IMVT cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: 0.00
IMVT cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 0.00
IMVT balance_sheet (annual, 2022-03-31) — Prepaid Assets: 6253000.00
IMVT cash_flow (annual, 2022-03-31) — Repayment Of Debt: 0.00
IMVT income_statement (annual, 2023-03-31) — +Operating Expense: 208276000.00
IMVT income_statement (annual, 2023-03-31) — +Total Revenue: 0.00
IMVT balance_sheet (annual, 2023-03-31) — Accounts Payable: 1353000.00
IMVT balance_sheet (annual, 2023-03-31) — Accounts Receivable: 700000.00
IMVT balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 927976000.00
IMVT income_statement (annual, 2023-03-31) — Basic Average Shares: 123075329.00
IMVT income_statement (annual, 2023-03-31) — Basic EPS: -1.71
IMVT cash_flow (annual, 2023-03-31) — Beginning Cash Position: 493817000.00
IMVT cash_flow (annual, 2023-03-31) — Capital Expenditure: -197000.00
IMVT balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 1220000.00
IMVT balance_sheet (annual, 2023-03-31) — Capital Stock: 13000.00
IMVT balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 376532000.00
IMVT balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 376532000.00
IMVT cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Financing Activities: 70885000.00
IMVT cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Investing Activities: -197000.00
IMVT cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Operating Activities: -188193000.00
IMVT cash_flow (annual, 2023-03-31) — Change In Account Payable: -17124000.00
IMVT cash_flow (annual, 2023-03-31) — Change In Accrued Expense: 15568000.00
IMVT cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 0.00
IMVT cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -1145000.00
IMVT cash_flow (annual, 2023-03-31) — Change In Payable: -16968000.00
IMVT cash_flow (annual, 2023-03-31) — Change In Payables And Accrued Expense: -1400000.00
IMVT cash_flow (annual, 2023-03-31) — Change In Prepaid Assets: -20533000.00
IMVT cash_flow (annual, 2023-03-31) — Change In Receivables: 12225000.00
IMVT cash_flow (annual, 2023-03-31) — Change In Working Capital: -10853000.00
IMVT cash_flow (annual, 2023-03-31) — Changes In Account Receivables: 11764000.00
IMVT cash_flow (annual, 2023-03-31) — Changes In Cash: -117505000.00
IMVT balance_sheet (annual, 2023-03-31) — Common Stock: 13000.00
IMVT balance_sheet (annual, 2023-03-31) — Common Stock Equity: 362494000.00
IMVT cash_flow (annual, 2023-03-31) — Common Stock Issuance: 70500000.00
IMVT balance_sheet (annual, 2023-03-31) — Current Accrued Expenses: 32891000.00
IMVT balance_sheet (annual, 2023-03-31) — Current Assets: 404333000.00
IMVT balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 1173000.00
IMVT balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 1173000.00
IMVT balance_sheet (annual, 2023-03-31) — Current Liabilities: 43297000.00
IMVT cash_flow (annual, 2023-03-31) — Depreciation: 193000.00
IMVT cash_flow (annual, 2023-03-31) — Depreciation Amortization Depletion: 193000.00
IMVT cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 193000.00
IMVT income_statement (annual, 2023-03-31) — Diluted Average Shares: 123075329.00
IMVT income_statement (annual, 2023-03-31) — Diluted EPS: -1.71
IMVT income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -210960000.00
IMVT balance_sheet (annual, 2023-03-31) — Dueto Related Parties Current: 350000.00
IMVT income_statement (annual, 2023-03-31) — EBIT: -208276000.00
IMVT income_statement (annual, 2023-03-31) — EBITDA: -208083000.00
IMVT cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 220000.00
IMVT cash_flow (annual, 2023-03-31) — End Cash Position: 376532000.00
IMVT cash_flow (annual, 2023-03-31) — Financing Cash Flow: 70885000.00
IMVT cash_flow (annual, 2023-03-31) — Free Cash Flow: -188390000.00
IMVT balance_sheet (annual, 2023-03-31) — Gains Losses Not Affecting Retained Earnings: 852000.00
IMVT income_statement (annual, 2023-03-31) — General And Administrative Expense: 48019000.00
IMVT balance_sheet (annual, 2023-03-31) — Gross PPE: 1505000.00
IMVT cash_flow (annual, 2023-03-31) — Income Tax Paid Supplemental Data: 0.00
IMVT income_statement (annual, 2023-03-31) — Interest Income: 7578000.00
IMVT income_statement (annual, 2023-03-31) — Interest Income Non Operating: 7578000.00
IMVT balance_sheet (annual, 2023-03-31) — Invested Capital: 362494000.00
IMVT cash_flow (annual, 2023-03-31) — Investing Cash Flow: -197000.00
IMVT cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 70500000.00
IMVT balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 47000.00
IMVT balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 47000.00
IMVT cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 70500000.00
IMVT income_statement (annual, 2023-03-31) — Net Income: -210960000.00
IMVT income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -210960000.00
IMVT income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -210960000.00
IMVT income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -210960000.00
IMVT income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -210960000.00
IMVT cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -210960000.00
IMVT income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -210960000.00
IMVT income_statement (annual, 2023-03-31) — Net Interest Income: 7578000.00
IMVT income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 7578000.00
IMVT cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -272000.00
IMVT balance_sheet (annual, 2023-03-31) — Net PPE: 1505000.00
IMVT cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -197000.00
IMVT balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 362494000.00
IMVT income_statement (annual, 2023-03-31) — Normalized EBITDA: -198083000.00
IMVT income_statement (annual, 2023-03-31) — Normalized Income: -200960000.00
IMVT cash_flow (annual, 2023-03-31) — Operating Cash Flow: -188193000.00
IMVT income_statement (annual, 2023-03-31) — Operating Income: -208276000.00
IMVT income_statement (annual, 2023-03-31) — Operating Revenue: 0.00
IMVT balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 130329863.00
IMVT balance_sheet (annual, 2023-03-31) — Other Current Assets: 26916000.00
IMVT balance_sheet (annual, 2023-03-31) — Other Equity Adjustments: 852000.00
IMVT income_statement (annual, 2023-03-31) — Other Gand A: 48019000.00
IMVT income_statement (annual, 2023-03-31) — Other Income Expense: -10253000.00
IMVT cash_flow (annual, 2023-03-31) — Other Non Cash Items: 1131000.00
IMVT income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: -253000.00
IMVT balance_sheet (annual, 2023-03-31) — Other Properties: 1505000.00
IMVT income_statement (annual, 2023-03-31) — Other Special Charges: 10000000.00
IMVT balance_sheet (annual, 2023-03-31) — Payables: 1703000.00
IMVT balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 34594000.00
IMVT balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 7530000.00
IMVT balance_sheet (annual, 2023-03-31) — Preferred Shares Number: 10000.00
IMVT balance_sheet (annual, 2023-03-31) — Preferred Stock: 0.00
IMVT income_statement (annual, 2023-03-31) — Pretax Income: -210951000.00
IMVT cash_flow (annual, 2023-03-31) — Proceeds From Stock Option Exercised: 657000.00
IMVT cash_flow (annual, 2023-03-31) — Purchase Of PPE: -197000.00
IMVT balance_sheet (annual, 2023-03-31) — Receivables: 885000.00
IMVT income_statement (annual, 2023-03-31) — Reconciled Depreciation: 193000.00
IMVT income_statement (annual, 2023-03-31) — Research And Development: 160257000.00
IMVT income_statement (annual, 2023-03-31) — Restructuring And Mergern Acquisition: 10000000.00
IMVT balance_sheet (annual, 2023-03-31) — Retained Earnings: -566347000.00
IMVT income_statement (annual, 2023-03-31) — Selling General And Administration: 48019000.00
IMVT balance_sheet (annual, 2023-03-31) — Share Issued: 130329863.00
IMVT income_statement (annual, 2023-03-31) — Special Income Charges: -10000000.00
IMVT cash_flow (annual, 2023-03-31) — Stock Based Compensation: 32296000.00
IMVT balance_sheet (annual, 2023-03-31) — Stockholders Equity: 362494000.00
IMVT balance_sheet (annual, 2023-03-31) — Tangible Book Value: 362494000.00
IMVT income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
IMVT income_statement (annual, 2023-03-31) — Tax Provision: 9000.00
IMVT income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.00
IMVT balance_sheet (annual, 2023-03-31) — Taxes Receivable: 185000.00
IMVT balance_sheet (annual, 2023-03-31) — Total Assets: 405838000.00
IMVT balance_sheet (annual, 2023-03-31) — Total Capitalization: 362494000.00
IMVT balance_sheet (annual, 2023-03-31) — Total Debt: 1220000.00
IMVT balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 362494000.00
IMVT income_statement (annual, 2023-03-31) — Total Expenses: 208276000.00
IMVT balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 43344000.00
IMVT balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 1505000.00
IMVT balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 47000.00
IMVT income_statement (annual, 2023-03-31) — Total Unusual Items: -10000000.00
IMVT income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -10000000.00
IMVT balance_sheet (annual, 2023-03-31) — Working Capital: 361036000.00
IMVT income_statement (annual, 2024-03-31) — +Operating Expense: 270209000.00
IMVT income_statement (annual, 2024-03-31) — +Total Revenue: 0.00
IMVT balance_sheet (annual, 2024-03-31) — Accounts Payable: 7155000.00
IMVT balance_sheet (annual, 2024-03-31) — Accounts Receivable: 5337000.00
IMVT balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 1441518000.00
IMVT income_statement (annual, 2024-03-31) — Basic Average Shares: 138100577.00
IMVT income_statement (annual, 2024-03-31) — Basic EPS: -1.88
IMVT cash_flow (annual, 2024-03-31) — Beginning Cash Position: 376532000.00
IMVT cash_flow (annual, 2024-03-31) — Capital Expenditure: -360000.00
IMVT balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 138000.00
IMVT balance_sheet (annual, 2024-03-31) — Capital Stock: 14000.00
IMVT balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 635365000.00
IMVT balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 635365000.00
IMVT cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: 472427000.00
IMVT cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: -360000.00
IMVT cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Operating Activities: -214227000.00
IMVT cash_flow (annual, 2024-03-31) — Change In Account Payable: 5784000.00
IMVT cash_flow (annual, 2024-03-31) — Change In Accrued Expense: 1349000.00
IMVT cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 0.00
IMVT cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -1172000.00
IMVT cash_flow (annual, 2024-03-31) — Change In Payable: 5455000.00
IMVT cash_flow (annual, 2024-03-31) — Change In Payables And Accrued Expense: 6804000.00
IMVT cash_flow (annual, 2024-03-31) — Change In Prepaid Assets: 1558000.00
IMVT cash_flow (annual, 2024-03-31) — Change In Receivables: -4558000.00
IMVT cash_flow (annual, 2024-03-31) — Change In Working Capital: 2632000.00
IMVT cash_flow (annual, 2024-03-31) — Changes In Account Receivables: -4577000.00
IMVT cash_flow (annual, 2024-03-31) — Changes In Cash: 257840000.00
IMVT balance_sheet (annual, 2024-03-31) — Common Stock: 14000.00
IMVT balance_sheet (annual, 2024-03-31) — Common Stock Equity: 617757000.00
IMVT cash_flow (annual, 2024-03-31) — Common Stock Issuance: 472745000.00
IMVT balance_sheet (annual, 2024-03-31) — Current Accrued Expenses: 26556000.00
IMVT balance_sheet (annual, 2024-03-31) — Current Assets: 665770000.00
IMVT balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 138000.00
IMVT balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 138000.00
IMVT balance_sheet (annual, 2024-03-31) — Current Liabilities: 48608000.00
IMVT cash_flow (annual, 2024-03-31) — Depreciation: 231000.00
IMVT cash_flow (annual, 2024-03-31) — Depreciation Amortization Depletion: 231000.00
IMVT cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 231000.00
IMVT income_statement (annual, 2024-03-31) — Diluted Average Shares: 138100577.00
IMVT income_statement (annual, 2024-03-31) — Diluted EPS: -1.88
IMVT income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -259336000.00
IMVT balance_sheet (annual, 2024-03-31) — Dueto Related Parties Current: 15000.00
IMVT income_statement (annual, 2024-03-31) — EBIT: -270209000.00
IMVT income_statement (annual, 2024-03-31) — EBITDA: -269978000.00
IMVT cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 993000.00
IMVT cash_flow (annual, 2024-03-31) — End Cash Position: 635365000.00
IMVT cash_flow (annual, 2024-03-31) — Financing Cash Flow: 472427000.00
IMVT cash_flow (annual, 2024-03-31) — Free Cash Flow: -214587000.00
IMVT balance_sheet (annual, 2024-03-31) — Gains Losses Not Affecting Retained Earnings: 1908000.00
IMVT income_statement (annual, 2024-03-31) — General And Administrative Expense: 57281000.00
IMVT balance_sheet (annual, 2024-03-31) — Gross PPE: 595000.00
IMVT cash_flow (annual, 2024-03-31) — Income Tax Paid Supplemental Data: 509000.00
IMVT income_statement (annual, 2024-03-31) — Interest Income: 24948000.00
IMVT income_statement (annual, 2024-03-31) — Interest Income Non Operating: 24948000.00
IMVT balance_sheet (annual, 2024-03-31) — Invested Capital: 617757000.00
IMVT cash_flow (annual, 2024-03-31) — Investing Cash Flow: -360000.00
IMVT cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 472745000.00
IMVT balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 0.00
IMVT balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 0.00
IMVT cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 472745000.00
IMVT income_statement (annual, 2024-03-31) — Net Income: -259336000.00
IMVT income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -259336000.00
IMVT income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -259336000.00
IMVT income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -259336000.00
IMVT income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -259336000.00
IMVT cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -259336000.00
IMVT income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -259336000.00
IMVT income_statement (annual, 2024-03-31) — Net Interest Income: 24948000.00
IMVT income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 24948000.00
IMVT cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -6012000.00
IMVT balance_sheet (annual, 2024-03-31) — Net PPE: 595000.00
IMVT cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -360000.00
IMVT balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 617757000.00
IMVT income_statement (annual, 2024-03-31) — Normalized EBITDA: -257478000.00
IMVT income_statement (annual, 2024-03-31) — Normalized Income: -249461000.00
IMVT cash_flow (annual, 2024-03-31) — Operating Cash Flow: -214227000.00
IMVT income_statement (annual, 2024-03-31) — Operating Income: -270209000.00
IMVT income_statement (annual, 2024-03-31) — Operating Revenue: 0.00
IMVT balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 145582999.00
IMVT balance_sheet (annual, 2024-03-31) — Other Current Assets: 24902000.00
IMVT balance_sheet (annual, 2024-03-31) — Other Equity Adjustments: 1908000.00
IMVT income_statement (annual, 2024-03-31) — Other Gand A: 57281000.00
IMVT income_statement (annual, 2024-03-31) — Other Income Expense: -13508000.00
IMVT cash_flow (annual, 2024-03-31) — Other Non Cash Items: 1130000.00
IMVT income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: -1008000.00
IMVT balance_sheet (annual, 2024-03-31) — Other Properties: 595000.00
IMVT income_statement (annual, 2024-03-31) — Other Special Charges: 12500000.00
IMVT balance_sheet (annual, 2024-03-31) — Payables: 7170000.00
IMVT balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 33726000.00
IMVT balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 14744000.00
IMVT balance_sheet (annual, 2024-03-31) — Preferred Shares Number: 10000.00
IMVT balance_sheet (annual, 2024-03-31) — Preferred Stock: 0.00
IMVT income_statement (annual, 2024-03-31) — Pretax Income: -258769000.00
IMVT cash_flow (annual, 2024-03-31) — Proceeds From Stock Option Exercised: 5694000.00
IMVT cash_flow (annual, 2024-03-31) — Purchase Of PPE: -360000.00
IMVT balance_sheet (annual, 2024-03-31) — Receivables: 5503000.00
IMVT income_statement (annual, 2024-03-31) — Reconciled Depreciation: 231000.00
IMVT income_statement (annual, 2024-03-31) — Research And Development: 212928000.00